/Investor DB

Company Ventures — 2026 Investments

5 investments dated 2026 · listed companies and verified rows first · show all

Boomboompay.appinAug 2026

Boom operates a leasing platform connecting property managers and renters through the full leasing process, from inquiry to approved resident.

FintechPropTechSaaSAustin, US

Rob Whiting(Co-founder & CEO)in

Co-investorsBungalow CapitalClocktower VenturesFox VenturesGaingelsMana VenturesMischief+6 more

Chamber Cardiochambercardio.comin𝕏Feb 2026

Chamber provides care coordination software for healthcare systems operating under value-based care models, with a specific focus on improving cardiovascular outcomes through better data alignment and team coordination.

Digital HealthEnterprise SoftwareHealthtech

George Aloth(Co-Founder & CEO)Jeffrey De Flavio(Founder)Sameer Sheth(Co-Founder, President & CMO)

Co-investorsAlleyCorpAmerican Family VenturesCity LightFrist Cressey VenturesGeneral CatalystOptum Ventures+2 more

Formularyformulary.clubJan 2026

Formulary Maison is a membership-based skincare and beauty club that sells premium formulations directly to Indian consumers at significantly discounted prices by eliminating retail intermediaries.

B2B MarketplacesConsumerDirect to ConsumerE-commerceWellness & FitnessIndia, IN

Co-investorsBetter CapitalAcrew CapitalAlumni VenturesHuman VenturesKhosla VenturesSerena Ventures

Kubera Healthkuberahealth.cominMay 2026 · $6.5M

New York, US

Roja Garimella, MD, MBA(Founder)inRoja Garimella(Executive Officer, Director)

Co-investorsDria VenturesSemperVirens Venture CapitalUpfront Ventures

Prosper AIgetprosper.aiinJun 2026 · $30M

Prosper provides AI agents to healthcare organizations to improve operational efficiency and patient access to care.

AI & Machine LearningEnterprise SoftwareHealthtechSaaSNew York City, US

Xavier de Gracia(Founder)inJosep Mingot(Founder)inEric Zielinski(COO)

Co-investorsAndreessen HorowitzEmergence Capital PartnersSiesta VenturesY CombinatorBase10 PartnersEWOR

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.